Montelukast

CAS Number
158966-92-8
EC Number
605-168-4

What is Montelukast?

Montelukast (CAS 158966-92-8) is a leukotriene receptor antagonist active pharmaceutical ingredient used in the treatment of asthma and allergic rhinitis.

Where is Montelukast used?

  • Pharmaceutical manufacturers and contract formulators: finished API for solid oral dosage development
  • Prescription and OTC oral tablets and chewable formulations targeting respiratory indications
  • Generic drug manufacturers: bioequivalent products following patent expiry
  • Pediatric chewable tablet formats: a distinct formulation segment
  • Analytical method development and pharmacokinetic research programs: key intermediate reference
  • It is an active procurement target across regulated and semi-regulated markets.

Commercial specifications

  • Standard grades: USP, BP, Ph. Eur.
  • Documentation packages support regulatory submissions in major markets
  • Bulk quantities for commercial manufacturing; smaller research-grade quantities for formulation development

Other Names (Synonyms)

Singulair®|Montélukast|Brondilat|MHM278SD3E|MONTELUKAST SODIUM

Contact us for supply of Montelukast

Request Quote

What are the physical properties of Montelukast?

Melting Point 84 °C
Boiling Point 750.5±60.0 °C(Predicted)
Density 1.272±0.06 g/cm3(Predicted)
Color Light yellow to yellow
Form A solid

How is Montelukast classified and handled safely? Learn More

Warning
GHS07· Irritant

Hazard Statements

H302 Harmful if swallowed
H312 Harmful in contact with skin
H332 Harmful if inhaled

Precautionary Statements

P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P264 Wash … thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P271 Use only outdoors or in a well-ventilated area.
Call Request Quote